WHO warns: Great care required for emergency authorization of COVID-19 vaccines
After the United States declared that it was considering a fast-tracking of the drug candidates, the World Health Organization said that the emergency authorization of COVID-19 vaccines needs a great deal of seriousness and concentration.
Soumya Swaminathan, chief scientist, World Health Organization said that even though every country had the right to authorize drugs without finishing complete clinical trials, and it is not something that we do very lightly.
Stephen Hahn, MD, Head of the United States FDA said that he would be ready to neglect the typical authorization procedure to approve a COVID-19 vaccine as long as authorities are convinced that the advantages surpass the threats.
After less than 2 months of human trials, Russia has given regulatory authorization to a COVID-19 vaccine in August, triggering some Western professionals to enquire about its safety and effectiveness.
Swaminathan stated that the World Health Organization’s favored strategy would certainly be to have a complete collection of data that could be used for vaccine pre-qualification. The World Health Organization would certainly consider the effectiveness as well as the safety of each medication based on each case.
Mike Ryan, the head of the organization’s emergency program said that the World Health Organization has previously fought Ebola in Africa utilizing speculative drugs – a measure proved to be successful.
However, Mike Ryan emphasized that a fast-track technique without full trials required intensive tracking as well as safety follow-up work, and should be halted quickly if any kind of troubles takes place.
Mike Ryan claimed that if the process of developing a vaccine is fast-forwarded, the vaccine may cause adverse effects putting the lives of millions of people at risk.
WHO warns: Great care required for emergency authorization of COVID-19 vaccines
Author: Sruthi S
